Virtify Delivers SaaS Clinical Trial Disclosure Solution for Mid-Market Life Sciences...( CAMBRIDGE Mass. Sep...),Health

CAMBRIDGE, Mass., Sept. 9 /PRNewswire/ -- Virtify, Inc., the market leader in enterprise content compliance software solutions for life sciences companies, today announced the availability of a new, Software-as-a-Service (SaaS) solution for managing clinical trial disclosure requirements. The Virtx Clinical Trial Registry & Results solution (Virtx CTRR) is a robust offering that automates compliance with global regulatory mandates and delivers rapid ROI by delivering best practices in regulatory information processing and eliminating upfront investments in hardware, software and implementation services.

New, evolving laws and mandates from global regulatory bodies and international health organizations such as the US FDA, World Health Organization, FDAAA, India CTRI, and the EMEA Authority, have dramatically increased public disclosure requirements for clinical trials and their results. As these authorities expand the requirements, e.g. the FDA's new adverse events reporting requirement effective September 27(th) 2009, many life sciences companies find themselves ill-equipped to comply due to manual or out-of-date systems. Without the proper processes and technology in place, companies run the risk of costly delays, penalties and lost market opportunities. This is especially true for small and mid-sized life sciences companies that lack the adequate internal staff and resources to achieve compliance.

Virtify's new SaaS CTRR solution helps mid-size life sciences organizations comply with the new regulations in a consistent, efficient and predictable manner. The software automates internal workflow and data gathering processes, as well as external workflow with various global regulatory ag
'/>"/>